Biofrontera received official review of its drug approval dossier for BF-200 ALA
23-Dec-2010
- Germany
According to the current understanding of Biofrontera management, the reviews are in line with the current temporal and financial planning. Thus, market introduction is still expected for the fall of 2011.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.